NewAmsterdam Pharma
Founded 2019 · 112 employees on LinkedIn · 5 known investors
Find your way into NewAmsterdam Pharma
Sign up to see every warm intro you have to NewAmsterdam Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NewAmsterdam Pharma team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NewAmsterdam Pharma develops innovative therapies for cardiovascular disease and lipid-related conditions. The company aims to provide lipid-lowering treatments that help patients with cardiovascular risk manage their health.
Investors · 5
How we know: Bain Capital Life Sciences's portfolio page · Not right? Tell us
How we know: BioGeneration Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: EQT Life Sciences's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Frazier Life Sciences's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
Founder mafia
2 people who came through NewAmsterdam Pharma went on to found or lead other companies.
Related companies · 4
Companies working in the same space as NewAmsterdam Pharma.
Frequently asked questions
- What does NewAmsterdam Pharma do?
- NewAmsterdam Pharma develops innovative therapies for cardiovascular disease and lipid-related conditions. The company aims to provide lipid-lowering treatments that help patients with cardiovascular risk manage their health.
- Who are NewAmsterdam Pharma's investors?
- NewAmsterdam Pharma's investors include Bain Capital Life Sciences, BioGeneration Ventures, EQT Life Sciences, Frazier Life Sciences, Forbion.






